| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $43K | -89.8% |
| R&D Expense | $6.7M | -65.3% |
| SG&A Expense | $5.4M | -19.7% |
| Operating Income | -$12.0M | +52.8% |
| Pre-tax Income | -$12.0M | +53.1% |
| Income Tax | -$782K | +73.9% |
| Net Income | -$11.2M | +50.3% |
| EPS (Basic) | -$2.09 | +92.2% |
| EPS (Diluted) | -$2.09 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.1M | -7.1% |
| Current Assets | $3.7M | -50.6% |
| Total Assets | $4.1M | -53.5% |
| Current Liabilities | $6.3M | -23.2% |
| Total Liabilities | $6.3M | -23.5% |
| Stockholders' Equity | -$2.2M | -458.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.0M | +50.4% |
| Capital Expenditures | $6K | +0.0% |
| Investing Cash Flow | -$6K | +0.0% |
| Financing Cash Flow | $7.8M | +822.4% |
| Free Cash Flow | -$8.0M | +50.4% |
| +92.2% |